Skip to main content

Table 3 Estimated risk for mental confusion according to patient sociodemographic and clinical characteristics

From: Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study

Characteristics

Confusion

N = 43

Without confusion

N = 245

Total

N = 288

p value

Raw OR (95% CI)

Adjusted OR (95% CI)a

Female sex, n (%)

18 (41.9)

117 (47.8)

135 (46.9)

0.48

0.78 (0.41–1.52)

Aged > 50 years, n (%)

32 (74.4)

112 (45.7)

144 (50)

< 0.01

3.46 (1.67—7.17)

3.76 (1.54—9.19)

Comorbidity, n (%)

40 (93)

172 (70.2)

212 (73.6)

< 0.01

5.66 (1.70—18.88)

3.13 (0.84—11.68)

FLU SYMPTOMS:

Fever, n (%)

32 (74.4)

167 (68.2)

199 (69.1)

0.41

1.36 (0.65—2.84)

Chills, n(%)

21 (48.8)

98 (40)

119 (41.3)

0.28

1.43 (0.75—2.74)

Cough, n(%)

32 (74.4)

164 (67)

196 (68.1)

0.33

1.44 (0.69—3.00)

Sore throat, n(%)

17 (39.5)

86 (35.1)

103 (35.8)

0.58

1.21 (0.62—2.35)

Dyspnoea, n (%)

38 (88.4)

185 (75.5)

223 (77.4)

0.06

2.47 (0.93—6.55)

Chest pain, n (%)

18 (42)

88 (33.1)

99 (34.4)

0.26

1.46 (0.75—2.83)

Low oxygenation, n (%)

33 (76.7)

132 (54)

165 (57.3)

< 0.01

2.83 (1.33—5.98)

2.11 (0.91—4.92)

Cyanosis, n (%)

9 (21)

16 (6.5)

25 (8.7)

< 0.01

3.79 (1.55—9.25)

1.29 (0.45—3.72)

Coryza, n (%)

17 (39.5)

82 (33.5)

99 (34.4)

0.44

1.33 (0.67—2.53)

Joint pain, n (%)

21 (48.8)

82 (33.5)

103 (35.8)

0.05

1.90 (0.99—3.65)

Diarrhea, n (%)

16 (37.2)

95 (38.8)

111 (38.5)

0.85

0.94 (0.48—1.83)

Nausea, n (%)

14 (32.6)

80 (32.7)

94 (32.6)

0.99

0.99 (0.50—1.99)

Vomiting, n (%)

12 (28)

55 (22.4)

67 (23.3)

0.44

1.34 (0.64—2.78)

Abdominal pain, n (%)

19 (44.2)

51 (21)

70 (24.3)

< 0.01

3.01 (1.53—5.92)

Flu, n (%)

42 (97.7)

234 (95.5)

276 (95.8)

0.51

SARS, n (%)

43 (100)

239 (97.6)

282 (98)

0.30

NEUROLOGICAL SYMPTOMS:

Headache, n (%)

26 (60.5)

173 (70.6)

199 (69.1)

0.18

0.64 (0.33—1.24)

Anosmia/Ageusia, n (%)

33 (76.7)

175 (71.4)

208 (72.2)

0.47

1.32 (0.62—2.82)

Myalgia, n (%)

21 (48.8)

107 (43.7)

128 (44.4)

0.53

1.23 (0.64—2.36)

Fatigue, n (%)

32 (74.4)

164 (67)

196 (68.1)

0.33

1.44 (0.69—3.00)

Somnolence, n (%)

22 (51.2)

85 (34.7)

107 (37.2)

0.04

1.97 (1.03—3.79)

1.33 (0.62—2.86)

Agitation, n (%)

18 (42)

42 (17.1)

60 (20.8)

< 0.01

3.48 (1.74—6.95)

2.76 (1.29—5.94)

Syncope, n (%)

4 (9.3)

10 (4.1)

14 (5)

0.14

2.41 (0.72—8.07)

Seizure, n (%)

5 (11.6)

3 (1.2)

8 (2.8)

< 0.01

10.61 (2.44—46.24)

27.2 (4.52—164.6)

  1. Variables considered to the model: age, comorbidity, dyspnoea, low oxygenation, cyanosis, joint pain, abdominal pain, somnolence, agitation, Seizure
  2. aFinal Model: seizure, agitation, age, comorbidity, cyanosis, low oxygenation, and somnolence